Mood state improvement agent

Collagen peptides with specific molecular weights degraded by microbial proteases effectively improve mood and reduce fatigue in healthy individuals, addressing the unclear relationship between collagen peptides and mental health.

JP2024157118AActive Publication Date: 2024-11-07JAPAN AIRCRAFT MFG CO LTD
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
JP2023071256
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-04-25
Publication Date
2024-11-07
Estimated Expiration
2043-04-25

AI Technical Summary

Technical Problem

There is a lack of clear understanding of the relationship between collagen peptides and their effect on mood improvement, particularly for healthy individuals, and mental fatigue can lead to depression and reduced work efficiency.

Method used

Administering collagen peptides with an average molecular weight of 500 to 12,000, degraded by microbial proteases, to healthy individuals for 8 weeks, which improves mood and reduces fatigue.

Benefits of technology

The administration of collagen peptides with specific molecular weights degraded by microbial proteases significantly improves mood and vitality in healthy individuals, as evidenced by reduced fatigue and increased vigor scores.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024157118000001
    Figure 2024157118000001
  • Figure 2024157118000002
    Figure 2024157118000002
  • Figure 2024157118000003
    Figure 2024157118000003
Patent Text Reader

Abstract

To provide a mood state improvement agent and a fatigue feeling improvement food for a healthy person, including collagen peptide.SOLUTION: A mood state improvement agent incudes as a primary component collagen peptide having an average molecular weight of 500-12,000, the collagen peptide decomposed by microorganism-derived protease. The collage peptide can, when orally administered to a healthy person who is self-aware of being liable to fall sick, improved, with statistically significant difference, fatigue-impotence (FI) evaluation and vitality-activity (VA) evaluation evaluated by POMS2.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to an agent for improving mood states in healthy individuals, comprising collagen peptides. [Background technology]

[0002] Collagen is a structural protein of skin, tendons, cartilage, etc., and is a unique protein in that it has a repeating unit of -(Gly-XY)n- (X and Y are any amino acid) and contains hydroxyproline by post-translational modification. Most collagens have a triple helix structure in vivo, in which three polypeptide chains with a molecular weight of about 100,000 are bound in a helical shape, but when this is decomposed by enzymes, acids, or alkalis, it becomes a polypeptide with a chain length and composition depending on the degree of decomposition and the difference in enzymes. For example, when gelatin is decomposed with a protease derived from Clostridium, it becomes a polypeptide whose main component is -(Gly-XY)n- (X and Y are any amino acid), and when it is decomposed with an enzyme derived from ginger rhizome, a peptide composition represented by X-Hyp-Gly (X is an amino acid residue other than Gly, Hyp, and Pro) is obtained (Patent Document 1).

[0003] It has been reported that orally ingesting collagen peptides broken down by an enzyme derived from ginger rhizome releases Pro-Hyp into the blood, which promotes the proliferation of hippocampal cells and exerts an antidepressant-like effect (Non-Patent Document 1).

[0004] Furthermore, with regard to collagen peptides, there have been reports on DPP-4 inhibitors (Patent Document 2), immunostimulators (Patent Document 3), bone formation promoters (Patent Document 4), angiotensin-converting enzyme inhibitors (Patent Document 5), and the like.

[0005] On the other hand, it is known that overwork causes various health problems, and the Ministry of Health, Labor and Welfare has set up a website where workers can self-check their accumulated fatigue levels (Non-Patent Document 2). Early detection of physical and mental fatigue can avoid overwork, prevent lifestyle-related diseases and depression, and improve quality of life. There is a composition for improving, maintaining and / or improving attention function that contains an active ingredient, an enzymatic hydrolysate of whey protein containing a peptide with a specific amino acid sequence (Patent Document 6), and a food for improving poor health that contains an extract of the mantle of a scallop, improves vitality, suppresses depression, and recovers from fatigue (Patent Document 7). [Prior art documents] [Patent documents]

[0006] [Patent Document 1] Patent No. 6075656 [Patent Document 2] International Publication No. 2013 / 065832 [Patent Document 3] International Publication No. 2016 / 076276 [Patent Document 4] Patent No. 6860877 [Patent Document 5] Patent No. 7048270 [Patent Document 6] Patent No. 7011984 [Patent Document 7] Patent No. 7105456 [Non-patent literature]

[0007] [Non-Patent Document 1] “Prolyl-hydroxyproline, a collagen-derived dipeptide, enhances hippocampal cell proliferation, which leads to antidepressant-like effects in mice”, The FASEB Journal 34 (4), 5715-5723, 2020-03 Wiley [Non-Patent Document 2] https: / / kokoro.mhlw.go.jp / fatigue-check / worker.html Summary of the Invention [Problem to be solved by the invention]

[0008] As mentioned above, there are various reports on the efficacy of collagen peptides, and Non-Patent Document 1 reports an antidepressant effect, but the relationship between collagen peptides and mental fatigue and improvement of physical condition described in Patent Document 6 and Patent Document 7 is unclear. Even healthy people with no problems in brain function can feel depressed, not just those with dementia or depression. For example, fatigue has mental and physical causes, and mental fatigue appears as somnolence (sleepiness) and lethargy. If collagen peptides derived from biological components can prevent or improve mental fatigue, they can be safe, maintain and improve work efficiency, and improve the quality of life of each person by improving mood.

[0009] In view of the above-mentioned current situation, the present disclosure aims to provide an agent for improving the mood state of healthy people, a food for improving the sense of fatigue of healthy people, and the like, which contains collagen peptides. [Means for solving the problem]

[0010] The present inventors administered collagen peptides degraded with microbial proteases to healthy individuals who are prone to falling ill for eight weeks and evaluated their mood states using POMS2 (Profile of Mood States 2nd Edition) (trademark). They found that fatigue-lethargy (FI) and vigor-vitality (VA) scores improved with statistical significance compared to the placebo group, and thus completed the present disclosure.

[0011] That is, the present disclosure provides an agent for improving the mood state of healthy individuals, which comprises a collagen peptide having an average molecular weight of 500 to 12,000 that has been degraded with a microbial protease.

[0012] Furthermore, the present invention provides a food for improving fatigue in healthy individuals, which contains collagen peptides with an average molecular weight of 500 to 12,000 that have been decomposed with a microbial protease.

[0013] In addition, it provides foods that improve and maintain a positive mood for healthy people, containing collagen peptides with an average molecular weight of 500 to 12,000 that have been hydrolyzed with microbial proteases. Effect of the Invention

[0014] According to the present disclosure, there is provided a drug for improving the mood state of healthy people, a food for improving fatigue in healthy people, and the like, which contains a collagen peptide having an average molecular weight of 500 to 12,000 degraded with a microbial protease. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0015] The present disclosure relates to a mood improving agent or energy booster for healthy people, a food for improving fatigue in healthy people, and a food for improving and maintaining a positive mood in healthy people, which contains collagen peptides having an average molecular weight of 500 to 12,000 decomposed by a microbial protease. The present disclosure will be described in detail below.

[0016] The average molecular weight of the collagen peptide used in the present disclosure is 500 to 12,000, preferably 1,000 to 10,000, more preferably 2,000 to 8,000, and particularly preferably 4,000 to 8,000. The average molecular weight means the weight average molecular weight. Collagen has a "collagen-like sequence" represented by -(Gly-XY)n-(X and Y represent amino acids). It can be hydrolyzed with acid or alkali, and can be decomposed by microbial proteases such as Rhizopus, Aspergillus, Bacillus, and Streptomyces, and plant-derived proteases such as ginger rhizome enzyme. The peptide composition produced varies depending on the protease used. For example, Clostridium bacteria can obtain collagen peptides whose main component is the -(Gly-XY)n-(X and Y represent amino acids) sequence with glycine at the N-terminus by specifying an enzyme that cleaves between Y and Gly. On the other hand, when decomposed with an enzyme derived from ginger rhizome, a peptide composition represented by X-Hyp-Gly, X-Pro-Gly, or Gly-Pro-X (X is an amino acid residue other than Gly, Hyp, or Pro) in which the second amino acid residue from the C-terminus is Pro or Hyp can be obtained. The collagen peptide used in the present disclosure is decomposed with a protease derived from a microorganism so as to have the above average molecular weight. Some low molecular weight collagen peptides are resistant to digestion and exhibit physiological activity when taken orally. As described in Non-Patent Document 1, when an enzyme decomposition product derived from ginger rhizome is ingested, Pro-Hyp is present in the blood, which affects brain function and exerts an antidepressant effect. We compared the blood Pro-Hyp concentrations in humans who ingested 5 g of ginger rhizome-derived enzyme hydrolysate and microbial protease hydrolysate. The blood Pro-Hyp concentrations 30 minutes after ingestion were 8.1±5.4 nmol / ml for the ginger rhizome-derived enzyme hydrolysate and 4.6±3.0 nmol / ml for the microbial protease hydrolysate, with a statistically significant difference (p<0.05) being lower for the microbial protease hydrolysate. The Area Under the Curve up to 6 hours after ingestion was also statistically significantly lower (p<0.05) for the microbial protease hydrolysate.However, as shown in the examples below, it has been found that the above-mentioned collagen peptides, which have been decomposed with microbial proteases, can improve the mood state, as assessed by the internationally used POMS2 (trademark) scale, in healthy individuals who easily get tired and become ill, thereby reducing fatigue and improving vitality and energy.

[0017] The collagen peptide used in the present disclosure may be derived from any animal species, such as fish, such as tilapia, sea bream, salmon, birds, pigs, cattle, or other animals, and may be extracted from any tissue, such as fish scales, dermis, tendons, or bones. It is preferably derived from fish scales, pigs, cattle, or birds. In addition, collagen is known to be of types I to XXVIII, and any type may be used. It is preferably type I collagen. The isoelectric point of the collagen peptide differs depending on the production method, but in the present disclosure, the isoelectric point is preferably 7.0 to 9.5, and more preferably 7.5 to 8.5.

[0018] In the present disclosure, the term "healthy individuals" refers to individuals who are free of illness or disease and are healthy in mind and body. Additionally, the term "mood state improver" refers to an agent that reduces fatigue and improves motivation and vitality.

[0019] The mood improving agent, the food for improving fatigue in healthy people, and the food for improving and maintaining a positive mood in healthy people disclosed herein may contain flavorings, excipients, thickeners, sweeteners, plant extracts, and vitamins to the extent that the effects are not impaired. The dosage form may be any of powder, granules, pills, capsules, tablets, liquids, suspensions, and others, provided that the stability of the collagen peptide is ensured. In the case of powders and granules, it is preferable that they are soluble in water or hot water and do not gel even when the solution is cooled.

[0020] In the present disclosure, food refers to food that is in an edible state and can be directly used for consumption by animals, including humans. Therefore, the food may be the above-mentioned food as it is, or the food may be simply changed into a powder, granule, pellet, or other form. In addition, the food may be a liquid or jelly-like beverage obtained by adding water to the above-mentioned food and, if necessary, a thickener or flavoring agent, or a jelly obtained by solidifying the above-mentioned food with agar or gelatin.

[0021] The method of administration of the food for improving fatigue in healthy people and the food for improving and maintaining a positive mood in healthy people disclosed herein may be oral administration, or tube administration. In this disclosure, "food" includes nutritional supplements such as supplements; nasal, enteral, and other tube feeding agents. When used as food, there are no particular limitations on other ingredients added to the food, provided that they are usable as food. Water, proteins, carbohydrates, lipids, vitamins, minerals, organic acids, organic bases, fruit juice, flavors, and the like can be blended as ingredients.

[0022] Examples of nutritional supplements include liquids or gels obtained by processing the above-mentioned foods directly or by processing the above-mentioned food compositions into powder, granules, pellets, etc. and adding water or a thickener to the above-mentioned foods. The above-mentioned food compositions may also be added to any of the conventionally known supplements.

[0023] The intake amount is 0.1 to 30 g, more preferably 2 to 10 g, per day, calculated as the amount of collagen peptide. Hydroxyproline is an amino acid characteristic of collagen, and the amount of collagen peptide can be roughly calculated based on the amount of hydroxyproline. It may be taken in multiple divided doses per day.

[0024] The mood improving agent, food for improving fatigue in healthy people, and food for improving and maintaining a positive mood in healthy people disclosed herein may be taken before or after a meal, between meals, or at any other time, and may be mixed into food ingredients and cooked, and the cooked food ingredients may be ingested in this manner, or sprinkled on cooked food ingredients and ingested.

[0025] The disclosed improving agent, food for improving fatigue in healthy people, and food for improving and maintaining a positive mood in healthy people can be administered to healthy people to maintain their mood. They are also useful for people with mental fatigue caused by pressure, lethargy, and other mental fatigue, as well as healthy people who are prone to falling ill. Mental fatigue manifests itself as drowsiness, lethargy, etc. Preventing or improving mental fatigue can improve mood and improve the quality of daily life. EXAMPLES

[0026] The present disclosure will now be described in detail with reference to examples, but these examples are not intended to limit the present disclosure in any way.

[0027] Example 1 Evaluation was conducted in a randomized, placebo-controlled, double-blind, parallel-group comparative study using the Japanese version of POMS2, commissioned to Ortho Medico Co., Ltd. In addition to the 65 questions in POMS2, an original questionnaire using the Likert scale method and a diary-based physical condition questionnaire were also included.

[0028] The subjects of this experiment were healthy people aged 20 or over who easily get tired and fall ill. They were selected from entrants with relatively high fatigue-lethargy (FI) scores at screening. The subjects for analysis were 31 people each in the test food group and the placebo group, and were divided into two groups so that there would be no significant differences in age, sex, height, or IgE levels. Analysis was performed using PPS (Per protocol analysis set) and FAS (Full analysis set).

[0029] The subjects were: (i) those currently undergoing treatment for or with a history of malignant tumors, heart failure, or myocardial infarction; (ii) those with a pacemaker or implantable cardioverter defibrillator; (iii) those undergoing treatment for arrhythmia, liver disorder, kidney disorder, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic diseases; (iv) those who regularly consume foods for specified health uses, foods with functional claims, or other foods / drinks that are considered to have functional properties; (v) those who eat foods with a high lactic acid bacteria content, such as lactic acid bacteria drinks or fermented foods, for more than two days a week; (vi) those who consume foods with a high collagen / gelatin content (beef tendons, liver, tripe / horumon, pork trotters, chicken thighs, chicken wings / skin, chicken cartilage, fish, etc.); The following were excluded from the study: (i) those who eat fish skin, conger eel, eel, monkfish, jelly fish, collagen hotpot, gelatin, gummy candy, marshmallows, etc.) more than two days a week; (vii) those who regularly take medicines (including herbal medicines) or supplements; (viii) those with allergies (to medicines or test food-related foods), especially those with allergies to fish, collagen, or gelatin; (ix) those who suffer from hay fever; (x) those who have received a vaccine for influenza or other infectious diseases within the year prior to the date of obtaining consent; (xi) those who are currently smoking or have stopped smoking within the year prior to the date of obtaining consent; and (xii) those who are pregnant, breastfeeding, or intending to become pregnant during the study period.

[0030] The test drug used in the test food group was collagen peptide granules (product name "FCP-AG", derived from tilapia type I collagen, decomposed with microbial food proteases (derived from Rhizopus, Aspergillus, Bacillus, and Streptomyces), average molecular weight 4,000-8,000), and the placebo used in the placebo group was dextrin powder. Both groups took 5g twice a day (after breakfast and dinner) dissolved in about half a glass of cold or warm water. The intake period was 8 weeks.

[0031] Participants were asked to answer 65 questions from the POMS2 at screening, at the start of intake (before intake), 4 weeks after intake, and 8 weeks after intake. The answers were calculated for each item on a 7-item scale: Tension-Anxiety (TA), Depression-Dejection (DD), Anger-Hostility (AH), Vigor-Activity (VA), Fatigue-Inertia (FI), Confusion-Bewilderment (CB), and Friendliness (F), and were evaluated using the Total Mood Disturbance (TMD) score.

[0032] Measurement values ​​at each time point were compared between groups at each time point using a linear mixed model with covariates, time point, group, interaction between time point and group, interaction between baseline value and time point, and trial participant as factors, with the value at screening as the baseline value.

[0033] The results of POMS2 were as follows: (1) The actual measured values ​​of fatigue-lethargy (FI) are shown in the table below. The test food group reduced the FI value over time, but after 8 weeks of intake, the FI value was reduced more than the placebo group with a statistically significant difference (P=0.045).

[0034] [Table 1]

[0035] (2) The actual measured values ​​of fatigue-lethargy (FI) are shown in the table below. The test food group improved its VA value over time, but after 8 weeks of intake, it improved its VA value more than the placebo group with a statistically significant difference (P=0.002).

[0036] [Table 2]

[0037] (3) The actual measured values ​​of POMS2, excluding FI and VA, at screening, at the start of intake, 4 weeks after intake, and 8 weeks after intake are shown below. The scores of TMD (Total Mood Disturbance), Anger-Hostility (AH), Confusion-Bewilderment (CB), Depression-Dejection (DD), and Tension-Anxiety (TA) showed a tendency to decrease over time, but no statistically significant difference was detected. In addition, the score of Friendliness (F) fluctuated, and no statistically significant difference was detected.

[0038] [Table 3]

[0039] [Table 4]

[0040] [Table 5]

[0041] [Table 6]

[0042] In addition, an original questionnaire using the Likert scale method was conducted at screening, at the start of intake, 4 weeks after intake, and 8 weeks after intake. The questions were 1. "Shoulder stiffness and back pain", 2. "Tend to be constipated", 3. "Tend to have diarrhea", 4. "Fatigue does not go away even after sleeping overnight", 5. "Fatigue for no clear reason", 6. "Skin condition is bad", and 7. "Hands tend to get rough". Participants were asked to answer on a 6-point scale: 1. "Does not apply at all", 2. "Does not apply at all", 3. "Does not apply very much", 4. "Applies a little", 5. "Applies quite a bit", and 6. "Applies very much". The median, first quartile (Q1), and third quartile (Q3) of the measured values ​​were calculated and compared between groups using the Mann-Whitney U test. The results are shown in the table below. Eight weeks after starting intake, a statistically significant difference (P<0.05) was detected between the placebo group and the test food group in the category of "I can't get rid of fatigue even after a night's sleep."

[0043] [Table 7]

[0044] In addition, a diary-style health questionnaire was conducted (1. "Feeling feverish," 2. "Runny nose," 3. "Nasal congestion," 4. "Sore throat," 5. "Cough," 6. "General fatigue," 7. "Muscle pain," 8. "Joint pain," 9. "Chills"). When the cumulative number of days each symptom occurred for each study participant was compared between groups using a t-test, no statistical significance was detected for any symptom.

[0045] (Summary) Looking at the results of individual items in the test food group, the sub-items of VA, "7. Lively," "12. Positive mood," "55. Feeling good without worries," "57. Energetic," "60. Full of motivation," and "62. Active," were significantly higher than the placebo group at the time of the test 8 weeks after ingestion, while the sub-items of FI, "45. Tired," and "59. Exhausted," were significantly lower than the placebo group. Furthermore, in the original questionnaire, the test food group showed a significantly lower score for "Fatigue does not go away even after a night's sleep" at the time of the test 8 weeks after ingestion compared to the placebo group. From these results, it is believed that the intake of the test food reduced mood states related to fatigue and lethargy, and enhanced mood states related to vitality and energy, and fatigue recovery through sleep, thereby reducing the subjective feeling of fatigue and the occurrence of cold symptoms.

[0046] Various embodiments and modifications of the present disclosure are possible without departing from the broad spirit and scope of the present disclosure. The above-described embodiments are for explaining the present disclosure and do not limit the scope of the present disclosure. That is, the scope of the present disclosure is indicated by the claims, not the embodiments. Various modifications made within the scope of the claims and the scope of the disclosure equivalent thereto are considered to be within the scope of the present disclosure.

Claims

1. An agent for improving the mood state of healthy individuals, comprising collagen peptides having an average molecular weight of 500 to 12,000 that have been decomposed with a microbial protease.

2. A food for improving fatigue in healthy individuals, containing collagen peptides with an average molecular weight of 500 to 12,000 that have been decomposed with microbial proteases.

3. A food that helps improve and maintain a positive mood for healthy people, containing collagen peptides with an average molecular weight of 500 to 12,000 that have been broken down with microbial proteases.

Citation Information

Patent Citations

  • Collagen powder capable of improving intelligence

    CN109953340A

  • IGF-1 value-elevating agent

    JP2012116773A

  • Oral solution

    JP2019131517A

  • Anti-fatigue composition

    US20110217393A1

  • Food composition for suppressing muscle fatigue and / or sudden muscle pain

    WO2023022174A1